This study from South Africa highlights the importance of rectal Trichomonas vaginalis infection as a sexually transmitted infection among men who have sex with men (MSM). We report seven MSM presenting with rectal T. vaginalis infection. Two men presented with symptoms of proctitis; 5/7 had urethral coinfection with T. vaginalis. Rectal T. vaginalis infection should be considered in MSM in areas where genital infection is endemic. Sexually transmitted infections (STIs), in particular Chlamydia trachomatis and Neisseria gonorrhoeae, are common in men who have sex with men (MSM) in Africa. A study from Cape Town reported an overall prevalence of 24% among 200 MSM visiting a primary healthcare facility providing MSM-targeted sexual health services; the majority of men were asymptomatic.
Sexually transmitted infections (STIs), in particular Chlamydia trachomatis and Neisseria gonorrhoeae, are common in men who have sex with men (MSM) in Africa. A study from Cape Town reported an overall prevalence of 24% among 200 MSM visiting a primary healthcare facility providing MSM-targeted sexual health services; the majority of men were asymptomatic. 1 Rectal infection was common in this study (20%) with similar prevalence for C. trachomatis and N. gonorrhoeae infection (12%). Another study reported an overall prevalence of 11.6% for these rectal infections among Kenyan MSM before initiation of HIV preexposure prophylaxis in an urban setting. 2 Trichomonas vaginalis is the most common nonviral STI in Africa. 3 Women are more often affected, with prevalence reported up to 24% in South Africa, but urethral infection in men is not uncommon. 4, 5 For example, a study from Johannesburg, South Africa, showed that T. vaginalis is the etiological cause in 6.1% of cases of male urethritis syndrome. 6 Despite the significance of T. vaginalis as cause of urethral infection in men with urethral discharge, the occurrence of rectal T. vaginalis infection in African MSM remains undocumented.
To our knowledge, only a few studies have reported before on rectal T. vaginalis infection in MSM: 2/225 men (0.9%) tested positive in the study by Cosentino et al., 7 whereas 3/500 (0.6%) had a positive polymerase chain reaction (PCR) test for T. vaginalis in another study. 8 Both studies were conducted in the United States where the prevalence of T. vaginalis infection in the general population is much lower than in Africa. 9 In a study conducted in Coˆte d'Ivoire, where T. vaginalis infection is more common in the population, 2/94 (2.1%) male sex workers tested positive for rectal T. vaginalis.
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To determine the prevalence of urethral and rectal STIs among South African MSM, we analyzed specimens collected in a prospective study of STIs among MSM attending a public healthcare facility in Johannesburg, South Africa. 11, 12 Briefly, MSM (!18 years) with urethral discharge and/or signs of proctitis (i.e. rectal discharge and/or blood loss) were recruited in this study. After obtaining informed consent, they were tested for urethral and rectal STIs (C. trachomatis, N. gonorrhoeae, T. vaginalis, and Mycoplasma genitalium) by collecting, respectively, urine samples and clinician-collected rectal swabs, and treated as per local guidelines. A follow-up visit was conducted after six weeks if asymptomatic, or earlier in case of symptoms, and repeat STI testing was performed. The High Pure PCR Template Preparation Kit (Roche Diagnostics, Basel, Switzerland) was used to extract DNA from the swabs followed by real-time PCR on the LightCycler 480 Instrument (Roche Molecular Diagnostics, Mannheim, Germany) using a specific assay for targeted detection of T. vaginalis. 14 In addition, specific detection of M. genitalium was done using an in-house real-time PCR assay whereas the Presto CT/NG assay (Microbiome Ltd, Houten, The Netherlands) was used for detection of C. trachomatis and N. gonorrhoeae. 15, 16 Altogether, 7/78 individual MSM (9.0%; 95% CI 5.7-12%) tested positive for rectal T. vaginalis infection during the study period. Rectal swabs of 3/78 (3.8%; 95% CI 3.4-4.3%) men tested positive for T. vaginalis infection upon recruitment; two of these men had concurrent urethral T. vaginalis infection. At follow-up, 4/61 (6.6%; 95% CI 5.8-7.4%) MSM were positive for rectal T. vaginalis infection; three had concurrent urethral infection. All men were treated with metronidazole (oral, 400 mg TDS for seven days) and none of them had clinically persistent infection (i.e. urethral discharge, dysuria, or symptoms of proctitis).
The demographic, behavioral, and clinical characteristics of the seven individual MSM with rectal T. vaginalis infection are summarized in Table 1 . The age range was 24-40 years and four men were HIV infected. All men were gay identified and reported male sex partners; only one reported recent concurrent female sex partners. Anal penetration was reported by six men: five men reported receptive anal intercourse (RAI) and two reported the anal use of sex toys. In one case (MSM number five) there was no direct anal sexual contact reported. Most patients reported inconsistent condom use. Anal discharge was present in two patients with one having severe symptoms of proctitis. Rectal T. vaginalis infection was isolated in 6/7 men; coinfection with N. gonorrhoeae was observed in one case. Five men had concurrent urethral T. vaginalis infection; four of these also had urethral N. gonorrhoeae infection and two M. genitalium. This is the largest case series of rectal T. vaginalis infection in MSM reported to date. It shows that symptomatic and asymptomatic rectal T. vaginalis infection is common among MSM living in our area of high prevalence of genital infection. Although coinfection was detected in one MSM, our data suggest that T. vaginalis infection should be considered as an etiological agent in cases of proctitis in MSM. However, anal discharge in MSM is not included as a condition in the syndromic management guidelines in our setting. 17 Also, metronidazole is only added to the empirical treatment regimen in case the man reports a female sex partner with vaginal discharge; this was not the case in our study. T. vaginalis should be included in the debate when considering public health aspects of asymptomatic rectal STIs in MSM in Africa, since rectal STIs may increase susceptibility to and infectivity of HIV infection 18 and asymptomatic rectal STIs are likely to remain untreated as diagnostic tests are not routinely available in our resource-constrained setting.
Our observations suggest that T. vaginalis may circulate within the MSM network and is not the result of direct bridging of infection from concurrent sexual contact with women. All men were gay and reported gay sex partners; only one also reported recent sexual contact with women. In five men a potential urethral T. vaginalis infection of the partner could have been transmitted to the rectum during RAI. The anal use of sex toys would be a possible way of transmission between two men, since transmission of T. vaginalis without anal penetration and by use of fingers has been described. 19 The route of acquisition of the rectal infection in one patient remains unclear as he did not report any direct anal sexual contact.
A limitation of this study is that, despite the assay's high specificity, we cannot rule out the possibility of misclassification of other non-vaginalis trichomonad species which are (harmless) inhabitants of the rectum. However, 5/7 men had concurrent urethral T. vaginalis infection where these pathogens do not occur, suggesting true rectal T. vaginalis infection. More importantly, presence of T. vaginalis infection was confirmed independently by two different molecular assays making such misclassification very unlikely.
In conclusion, we show that rectal T. vaginalis is an important infection in MSM living in an area where genital infection is endemic. More research is required to prove that the infection should be considered in the differential diagnosis of proctitis in MSM in our area and, in the absence of diagnostic tests, probably be covered in the empirical treatment choice. T. vaginalis should be considered when addressing the public health impact of rectal STIs among MSM in South Africa.
